Drug intelligence / Profile preview

3-(hydroxy-phenyl-phosphinoyloxy)-8-methyl-8-aza-bicyclo[3.2.1]octane-2-carboxylic acid methyl ester

Development stage: Unknown
Modality: Small Molecules

Overview

This compound is an experimental small molecule with the chemical formula C16H22NO5P and a molecular weight of approximately 339.32 g/mol[1][2]. It is structurally characterized as a phosphinic acid ester derivative of tropane, featuring both a phenylphosphinoyl group and a methylated azabicyclooctane core[1]. There is no publicly available information on its mechanism of action, pharmacological activity, clinical indication, or development status in humans or animals. The compound appears in chemical and structural databases but lacks evidence for clinical use or advanced preclinical development.

Beyond the preview

Go deeper on 3-(hydroxy-phenyl-phosphinoyloxy)-8-methyl-8-aza-bicyclo[3.2.1]octane-2-carboxylic acid methyl ester.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 3-(hydroxy-phenyl-phosphinoyloxy)-8-methyl-8-aza-bicyclo[3.2.1]octane-2-carboxylic acid methyl ester.

Explore the full profile